Prior to joining CyTerra, Mr. O’Donnell held various leadership positions at Lockheed Martin Missiles & Fire Control over 13 years.  Notable accomplishments: led the design of an innovative tri-mode seeker (radar, infrared, laser) for Joint Common Missile; initiated the novel transfer of radar technology to high bandwidth communications; led the successful pursuit of a concealed weapons detection contract.

Prior to joining Lockheed Martin, Mr. O’Donnell was an Engineering Supervisor at E-Systems Melpar Division, where he worked on advanced sensor development programs. He started his engineering career at Sperry Government Electronic Systems, where he worked on electronic warfare  training systems.  

Mr. O’Donnell is the inventor or co-inventor on numerous patent filings and issued patents in diverse areas, including:  missile guidance, through-wall motion sensing, IED detection, explosive detection, automated dimensioning devices, and umbrellas.

He received a BS in Electrical Engineering from Virginia Tech and an MS in Management of Technology from the University of Miami.

Dan O'Donnell, Founder and President of STINGR Solutions LLC, has over 26 years of experience in advanced technology development in engineering, program management and business development roles.  Always gravitating to the most challenging R&D efforts, he has been a leader in the strategic planning and engineering development of many innovative technologies, products and systems.    

Prior to founding STINGR in late 2007, Mr. O’Donnell was Vice President of Business Development at L-3 CyTerra Corporation (2006-2007), and held the same position at privately-held CyTerra (2002-2006) prior to its acquisition by L-3 Communications.   In this VPBD role, he was responsible for new business pursuits for the 2000 startup company.  He successfully led the rapid expansion of CyTerra’s technology and product portfolios through capture of Government R&D contracts, adding many new customers. Mr. O’Donnell was a key participant in CyTerra’s sale process, and he continues to consult for L-3 CyTerra.